NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been
filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to
request that the court appoint you as lead plaintiff.
MGT Capital Investments Inc. (OTCMKTS: MGTI)
Class Period: October 9, 2015 to September 7, 2018
Lead Plaintiff Deadline: November 27, 2018
MGT Capital Investments Inc. allegedly made materially false and/or misleading statements and/or failed to
disclose that: (1) Defendants were engaged in an illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price;
(2) the "Scheme Defendants"--Defendants Ladd, Honig, Stetson, Brauser, O’Rourke, and Groussman--had a history of engaging in
illegal conduct in connection with the purchase and sale of securities; (3) the Scheme Defendants were a “group”, pursuant to
Section 13 of the Exchange Act; (4) the Scheme Defendants exercised control over the Company; (5) the Company’s acquisition of
D-Vasive Inc. was part of Defendants’ illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price; (6)
Defendants’ illicit scheme caused MGT Capital to make false and misleading statements, which would result in governmental and
regulatory scrutiny; (7) the scheme would result in the delisting of MGT Capital’s stock from NYSE MKT; and (8) as a result,
Defendants’ statements about MGT Capital’s business and prospects were materially false and misleading and/or lacked a reasonable
basis at all relevant times.
Get additional information about the MGTI lawsuit: http://www.kleinstocklaw.com/pslra-1/mgt-capital-investments-inc-loss-submission-form?wire=3
Acadia Healthcare Company, Inc. (NASDAQGS: ACHC)
Class Period: February 23, 2017 to October 24, 2017
Lead Plaintiff Deadline: December 3, 2018
According to the complaint, Acadia Healthcare Company, Inc. allegedly made materially false and/or misleading
statements and/or failed to disclose that: (1) the quality of Acadia’s U.K. operations did not give the Company a “competitive
strength” that would drive future growth and profitability; and (2) defendants had no reasonable basis to believe--and did not in
fact believe--their positive statements about the Company’s business and financial prospects during the Class Period, including
their guidance issued and reaffirmed throughout the Class Period.
Get additional information about the ACHC lawsuit: http://www.kleinstocklaw.com/pslra-1/acadia-healthcare-company-inc-loss-submission-form?wire=3
Jianpu Technology Inc. (NYSE: JT)
Class Period: Pursuant and/or traceable to the initial public offering on or about November 16, 2017
Lead Plaintiff Deadline: December 24, 2018
The complaint alleges that the Company’s IPO offering materials contained inaccurate statements of material fact
and/or omitted material information required to be disclosed in order to make such statements not misleading, including failure to
disclose that the China Banking Regulatory Commission and three other Chinese regulators had issued rules in 2016 requiring
peer-to-peer lending companies to appoint qualified banking institutions as custodians and disclose their use of deposits. On
November 21, 2017, news outlets reported that China’s Financial Stability and Development Committee (“FSDC”) had issued an urgent
notice to provincial governments urging them to suspend regulatory approval of new internet micro-loan companies. Following this
news, Jianpu’s shares fell over 38% in three days and closed at $4.90 per share on November 24, 2017.
Get additional information about the JT lawsuit: http://www.kleinstocklaw.com/pslra-1/jianpu-technology-inc-loss-submission-form?wire=3
Huazhu Group Limited (NASDAQ: HTHT)
Class Period: May 14, 2018 to August 28, 2018
Lead Plaintiff Deadline: December 7, 2018
The lawsuit alleges Huazhu Group Limited made materially false and/or misleading statements and/or failed to
disclose during the class period that: (1) the Company lacked adequate security measures to protect customer information; (2) as a
result of the foregoing, the Company would be susceptible to increased litigation risk and higher expenses; (3) as a result of the
foregoing, the Company’s goodwill would potentially suffer, leading to lower revenues; and (4) as a result of the foregoing,
Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading
and/or lacked a reasonable basis.
Get additional information about the HTHT lawsuit: http://www.kleinstocklaw.com/pslra-1/huazhu-group-limited-loss-submission-form?wire=3
Altice USA, Inc. (NYSE: ATUS)
Class Period: Pursuant and/or traceable to the June 2017 Initial Public Offering
Lead Plaintiff Deadline: January 18, 2019
The complaint alleges that the Offering Documents issued pursuant to the IPO failed to disclose and/or misstated
material information, including that: (1) “The Altice Way” proprietary growth model previously developed in Europe and described in
the Offering Documents as a means to achieve superior margin performance was falsely touting Altice’s capacity to face already
existing highly competitive environments and ever-changing consumer behaviors; (2) Altice was suffering from aggressively growing
competition both in Europe and the United States, directly causing negative and decelerating revenue and EBITDA growth and
impacting Altice’s market share; (3) specifically, Altice was suffering from mismanaged rate events, regulatory compliance and
poorly managed network and customer care both in its France and Portugal segments, thereby impacting its customer base and churn
rate; (4) Altice USA could not simply replicate the “The Altice Way” in the U.S.; and (5) as a result, Altice USA’s Offering
Documents were materially misleading at all relevant times.
Get additional information about the ATUS lawsuit: http://www.kleinstocklaw.com/pslra-1/altice-usa-inc-atus-loss-submission-form?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or
obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J.
Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud
throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
